Skip to content

Survey to assess mucosal and humeral polio-immunity in Gadap, Karachi, Pakistan

Survey to assess mucosal and humoral poio-immunity in 1, 4, 9 and 14 year old children living in one of the last reservoirs of poliovirus endemic areas, in Gadap, Karachi, Pakistan

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000357156
Enrollment
600
Registered
2019-03-06
Start date
2019-05-01
Completion date
2019-05-15
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To better understand why wild poliovirus persists in Gadap, and other such areas in Pakistan, it is important to know the proportion and age of children that lack mucosal immunity despite repeated polio vaccination campaigns. These are the children who do not necessarily become paralyzed when infected with poliovirus (PV) but who harbour the PV and further transmit it to others; resulting in continued low level PV circulation that has been observed in Gadap and other areas. It is known that mucosal immunity rapidly wanes however it is less well understood to what extend this immunity wanes in populations repeatedly vaccinated with OPV. Currently, IPV is added to the routine immunization program in Pakistan and therefore it is possible that there is a growing cohort of children whose humoral immunity is present but mucosal is absent. We intend to quantify this proportion and determine whether there are possible programmatic strategies to target these children.

Interventions

Children in intervention arm will be 9-10 or 14-15 years old - these children are not included in periodic polio vaccination campaigns which target children under 5 years of age Children will receive one dose (two drops) of bivalent oral poliovirus vaccine (bOPV, Each dose [two-drops ~0.1 ml] contains not less than 10^6.0 CCID50 of Type 1 and 10^5.8 CCID50 of Type 3) as part of this study

Sponsors

World Health Organization
Lead SponsorOther

Study design

Allocation
Non-randomised trial
Primary purpose
Prevention

Eligibility

Sex/Gender
All
Age
1 Years to 15 Years
Healthy volunteers
Yes

Inclusion criteria

children living in study catchment area (Gadap Union Council 04, Karachi, Pakistan) aged 1-2 years or 4-5 years or 9-10 years or 14-15 years

Exclusion criteria

Suspected immunodeficiecny

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026